NASDAQ:AQST | Operating Income | Aquestive Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2017-06-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$8.22M
2026-03-31-$4.2M
2025-12-31-$28.84M
2025-09-30-$11.48M
2025-06-30-$11.37M
2025-03-31-$19.37M
2024-12-31-$13.58M
2024-09-30-$8.29M
2024-06-30$55,000.00
2024-03-31-$8.96M
2023-12-31-$3.91M
2023-09-30-$2.38M
2023-06-30-$4.21M
2023-03-31-$4.61M
2022-12-31-$10.71M
2022-09-30-$8.85M
2022-06-30-$12.76M
2022-03-31-$9.74M
2021-12-31-$11.67M
2021-09-30-$7.97M
2021-06-30-$6.52M
2021-03-31-$8.53M
2020-12-31-$15.65M
2020-09-30-$13.78M
2020-06-30$395,000.00
2020-03-31-$13.86M
2019-12-31-$9.9M
2019-09-30-$11M
2019-06-30-$18.69M
2019-03-31-$13.07M
2018-12-31-$12.35M
2018-09-30-$9.21M
2018-06-30-$32.71M
2018-03-31$5.31M
2017-12-31-$7.26M
2017-09-30$10.42M
2017-06-30-$4.06M

Annual Operating Income

DateOperating Income
2025-12-31-$71.05M
2024-12-31-$30.77M
2023-12-31-$15.1M
2022-12-31-$42.07M
2021-12-31-$34.68M
2020-12-31-$42.89M
2019-12-31-$52.67M
2018-12-31-$48.93M
2017-12-31-$113,000.00